Insider Selling: SI-BONE, Inc. (NASDAQ:SIBN) CFO Sells $73,778.64 in Stock

SI-BONE, Inc. (NASDAQ:SIBN) CFO Anshul Maheshwari sold 5,304 shares of the company’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $13.91, for a total transaction of $73,778.64. Following the completion of the sale, the chief financial officer now directly owns 189,319 shares in the company, valued at $2,633,427.29. This represents a 2.73 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Anshul Maheshwari also recently made the following trade(s):

• On Monday, November 18th, Anshul Maheshwari sold 2,439 shares of SI-BONE stock. The stock was sold at an average price of $12.68, for a total transaction of $30,926.52.

SI-BONE Trading Up 1.8 %

NASDAQ:SIBN opened at $14.40 on Thursday. SI-BONE, Inc. has a 52 week low of $11.70 and a 52 week high of $21.64. The stock has a market cap of $603.91 million, a price-to-earnings ratio of -15.65 and a beta of 1.16. The company’s 50 day moving average price is $13.66 and its 200-day moving average price is $14.17. The company has a quick ratio of 7.22, a current ratio of 8.25 and a debt-to-equity ratio of 0.22.

Institutional Trading of SI-BONE

Institutional investors have recently added to or reduced their stakes in the business. Rhumbline Advisers lifted its holdings in shares of SI-BONE by 1.5% during the second quarter. Rhumbline Advisers now owns 59,419 shares of the company’s stock valued at $768,000 after purchasing an additional 852 shares in the last quarter. Arizona State Retirement System raised its position in SI-BONE by 9.0% in the 2nd quarter. Arizona State Retirement System now owns 10,921 shares of the company’s stock worth $141,000 after buying an additional 903 shares during the last quarter. The Manufacturers Life Insurance Company lifted its stake in SI-BONE by 7.5% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 15,880 shares of the company’s stock valued at $205,000 after acquiring an additional 1,105 shares during the period. FMR LLC boosted its holdings in shares of SI-BONE by 103.6% during the 3rd quarter. FMR LLC now owns 2,354 shares of the company’s stock valued at $33,000 after acquiring an additional 1,198 shares during the last quarter. Finally, Franklin Resources Inc. grew its stake in shares of SI-BONE by 9.4% in the third quarter. Franklin Resources Inc. now owns 20,220 shares of the company’s stock worth $265,000 after acquiring an additional 1,745 shares during the period. 98.11% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Needham & Company LLC reissued a “buy” rating and issued a $19.00 price target on shares of SI-BONE in a research report on Wednesday, November 20th. Truist Financial boosted their target price on SI-BONE from $16.00 to $18.00 and gave the stock a “buy” rating in a report on Wednesday, November 13th. Six analysts have rated the stock with a buy rating, According to MarketBeat, SI-BONE currently has a consensus rating of “Buy” and an average target price of $23.00.

SI-BONE Company Profile

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.